Status: current, Defined. Date: 31-Oct 2010. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 937943011000036112 | gadoteridol 5.59 g/20 mL injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 937944011000036114 | gadoteridol 5.59 g / 20 mL injection, 20 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| gadoteridol 5.59 g/20 mL injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| gadoteridol 5.59 g/20 mL injection, vial | Is a | gadoteridol | true | Inferred relationship | Some | ||
| gadoteridol 5.59 g/20 mL injection, vial | has intended active ingredient | gadoteridol | true | Inferred relationship | Some | 2067209000 | |
| gadoteridol 5.59 g/20 mL injection, vial | has Australian BoSS | gadoteridol | true | Inferred relationship | Some | 2067209000 | |
| gadoteridol 5.59 g/20 mL injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| gadoteridol 5.59 g/20 mL injection, vial | has unit of use | vial | true | Inferred relationship | Some | 2067209001 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Prohance 5.59 g/20 mL injection, 20 mL vial | Is a | True | gadoteridol 5.59 g/20 mL injection, vial | Inferred relationship | Some | |
| gadoteridol 5.59 g/20 mL injection, 10 x 20 mL vials | has MPUU | True | gadoteridol 5.59 g/20 mL injection, vial | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR